53
Participants
Start Date
October 31, 2012
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
Placebo
Single ascending dose
RO5545965
Single ascending dose
RO5545965
Single dose, in fed and fasted state
Zuidlaren
Hoffmann-La Roche
INDUSTRY